Provided by Tiger Trade Technology Pte. Ltd.

KALA BIO

0.6091
-0.0309-4.83%
Post-market: 0.62100.0119+1.95%19:58 EST
Volume:635.75K
Turnover:390.53K
Market Cap:16.96M
PE:-0.10
High:0.6282
Open:0.6168
Low:0.6051
Close:0.6400
52wk High:20.60
52wk Low:0.5100
Shares:27.85M
Float Shares:23.25M
Volume Ratio:0.20
T/O Rate:2.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8254
EPS(LYR):-10.1450
ROE:-708.34%
ROA:-65.81%
PB:-1.96
PE(LYR):-0.06

Loading ...

KALA BIO Inc - on Jan 8, Enters Agreement With H.c. Wainwright - SEC Filing

THOMSON REUTERS
·
Jan 09

KALA BIO Launches At-the-Market Equity Offering Program

TIPRANKS
·
Jan 09

BRIEF-Kala Bio Settles Approximately $10.6 Million Of Debt

Reuters
·
Jan 06

Kala Bio Settles $10.6 Million Debt with Oxford Finance

Reuters
·
Jan 06

KALA BIO Settles Approximately $10.6 Million of Debt

THOMSON REUTERS
·
Jan 06

KALA BIO Inc - Pays $2 Mln to Oxford Finance Llc as Part of Settlement Agreement, Settles All Obligations - SEC Filing

THOMSON REUTERS
·
Jan 03

Kala Bio Inc. Settles $10.6 Million Debt with $2 Million Payment to Oxford Finance

Reuters
·
Jan 03

Kala Bio Inc. Announces Date for 2025 Annual Meeting of Stockholders

Reuters
·
Dec 31, 2025

Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading?

Benzinga_recent_news
·
Dec 24, 2025

KALA BIO Raises $10 Million From Direct Offering

MT Newswires Live
·
Dec 06, 2025

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:45 AM

Reuters
·
Dec 04, 2025

KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Dec 04, 2025

KALA BIO Inc - Purchase Price Set at $1.00 per Share in Direct Offering

THOMSON REUTERS
·
Dec 04, 2025

Press Release: KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Dow Jones
·
Dec 04, 2025

Why Did KALA BIO Shares Jump Over 22% After Hours?

Benzinga_recent_news
·
Dec 04, 2025

Kala Bio Inc. Files Initial Beneficial Ownership Statement Naming Oxford Finance LLC

Reuters
·
Dec 04, 2025

Top Midday Gainers

MT Newswires Live
·
Dec 02, 2025

KALA BIO Inc: Continuing to Evaluate and Redevelop Co's Product Candidates While Actively Exploring Strategic Opportunities

THOMSON REUTERS
·
Dec 01, 2025

KALA BIO Inc - David E. Lazar Appointed as Kala's CEO and Chairman

THOMSON REUTERS
·
Dec 01, 2025

KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

GlobeNewswire
·
Dec 01, 2025